Cohance Lifesciences Ltd
NSE:COHANCE

Watchlist Manager
Cohance Lifesciences Ltd Logo
Cohance Lifesciences Ltd
NSE:COHANCE
Watchlist
Price: 378.4 INR 0.91% Market Closed
Market Cap: ₹144.8B

Profitability Summary

Cohance Lifesciences Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Cohance Lifesciences Ltd

Margins Comparison
Cohance Lifesciences Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Cohance Lifesciences Ltd
NSE:COHANCE
143.8B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cohance Lifesciences Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Cohance Lifesciences Ltd
NSE:COHANCE
143.8B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cohance Lifesciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate